Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

Topical DHEA safely increases skin oil production.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Testosterone increases hamster hair growth; cyproterone acetate reduces it.

High doses of finasteride cause cell growth and tumors in mice.

Androgens prevent hair growth by changing Wnt signals in cells.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Methylation in specific gene region causes finasteride resistance in some BPH patients.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

DHT, not testosterone, mainly affects hair growth and related conditions.

Finasteride treatment can decrease certain steroids and increase others, possibly leading to depression symptoms in some cases.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

Dihydrotestosterone affects hair growth by changing the Wnt/β-catenin pathway, with low levels helping and high levels hindering growth.

Finasteride may reduce prostate cancer risk.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.